Vol. 22 No. 6 (2024): Blood Transfusion 6-2024 (November-December)

Full Issue pdf

Commentary

The new SoHO Regulation. What should the blood system expect? New SoHO regulation

Simonetta Pupella
Inclusion of cryoprecipitate, pathogen-reduced, in the who model lists of essential medicines for adults and children: a call for action: Cryo-PR in the WHO EML

Jay Epstein, Yuyun Maryuningsih, Jean-Claude Faber, W. Martin Smid, Thierry Burnouf

Review

The SARS-CoV-2 infection rebound among patients receiving antiviral agents, convalescent plasma, or no treatment: a systematic review with meta-analysis: SARS-CoV-2 infection rebound

Ilaria Pati, Mario Cruciani, Francesca Masiello, Vanessa Piccinini, Simonetta Pupella, Vincenzo De Angelis

Original article

Announcements

Winter Closure

The Editorial Office will be closed from December 31 to January 7, 2026.

Season’s greetings to all our readers, authors, and reviewers.

SIMTI 2026

46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)

SETS 2026

35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).

Madrid, 4-6 June 2026.

Editorial Office Closure Notice

Please note that the BT Editorial Office will be closed until August 26, 2026.

During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.

Thank you for your understanding.

Best regards,
BT Editorial Office

Impact Factor 2025

We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.

Vol. 22 No. 6 (2024): Blood Transfusion 6-2024 (November-December)

Full Issue pdf

Commentary

The new SoHO Regulation. What should the blood system expect? New SoHO regulation

Inclusion of cryoprecipitate, pathogen-reduced, in the who model lists of essential medicines for adults and children: a call for action: Cryo-PR in the WHO EML

Review

The SARS-CoV-2 infection rebound among patients receiving antiviral agents, convalescent plasma, or no treatment: a systematic review with meta-analysis: SARS-CoV-2 infection rebound

Original article

Genomic characterisation of clinically significant blood group variants in Aboriginal Australians: Blood group diversity in Aboriginal Australians

Development and evaluation of trigger tools to identify pediatric blood management errors: Trigger tools for pediatric blood management errors

Assessment of metabolic and hemostatic profile of apheresis platelet concentrates: does the storage medium play a role? Comparison of apheresis platelets stored in PAS and plasma

Blood transfusion-associated anaphylaxis in perioperative- and non-perioperative patients in Western Norway 2002-2021: Transfusion-associated anaphylaxis

In vitro regenerative effects of a pooled pathogen-reduced lyophilized human cord blood platelet lysate for wound healing applications: Human cord blood platelet lysate for wound healing applications

Ten years of a neonatal screening program for hemoglobinopathies in Friuli-Venezia Giulia: first regional experience in Italy: Screening newborns for hemoglobinopathies in Friuli-Venezia Giulia

Brief report

Identification of the novel c.300C>G variation on the ABOA1.02 allele associated with an AweakB phenotype: A new variant A allele on ABOA1.02

Case report

Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B40:02: HSCT for Aplastic Anemia with HLA-B40:02

Letter to the Editor

Implementing Patient Blood Management in major digestive surgery: should we do more? Implementing PBM issues

Announcements

Winter Closure

SIMTI 2026

SETS 2026

Editorial Office Closure Notice

Impact Factor 2025

Information

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Vol. 22 No. 6 (2024): Blood Transfusion 6-2024 (November-December)

Full Issue pdf

Commentary

The new SoHO Regulation. What should the blood system expect? New SoHO regulation

Inclusion of cryoprecipitate, pathogen-reduced, in the who model lists of essential medicines for adults and children: a call for action: Cryo-PR in the WHO EML

Review

The SARS-CoV-2 infection rebound among patients receiving antiviral agents, convalescent plasma, or no treatment: a systematic review with meta-analysis: SARS-CoV-2 infection rebound

Original article

Genomic characterisation of clinically significant blood group variants in Aboriginal Australians: Blood group diversity in Aboriginal Australians

Development and evaluation of trigger tools to identify pediatric blood management errors: Trigger tools for pediatric blood management errors

Assessment of metabolic and hemostatic profile of apheresis platelet concentrates: does the storage medium play a role? Comparison of apheresis platelets stored in PAS and plasma

Blood transfusion-associated anaphylaxis in perioperative- and non-perioperative patients in Western Norway 2002-2021: Transfusion-associated anaphylaxis

In vitro regenerative effects of a pooled pathogen-reduced lyophilized human cord blood platelet lysate for wound healing applications: Human cord blood platelet lysate for wound healing applications

Ten years of a neonatal screening program for hemoglobinopathies in Friuli-Venezia Giulia: first regional experience in Italy: Screening newborns for hemoglobinopathies in Friuli-Venezia Giulia

Brief report

Identification of the novel c.300C>G variation on the ABO*A1.02 allele associated with an AweakB phenotype: A new variant A allele on ABO*A1.02

Case report

Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02: HSCT for Aplastic Anemia with HLA-B*40:02

Letter to the Editor

Implementing Patient Blood Management in major digestive surgery: should we do more? Implementing PBM issues

Announcements

Winter Closure

SIMTI 2026

SETS 2026

Editorial Office Closure Notice

Impact Factor 2025

Information

Banner

Identification of the novel c.300C>G variation on the ABOA1.02 allele associated with an AweakB phenotype: A new variant A allele on ABOA1.02

Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B40:02: HSCT for Aplastic Anemia with HLA-B40:02